Spago Nanomedical AB (publ) (SPAGO.ST)
SEK 0.19
(7.39%)
SEK 0.19
(7.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -44.9 Million | -38.18 Million | -35.56 Million | -18.76 Million | -21.28 Million | -10.51 Million |
| Net Income | -42.22 Million | -39.46 Million | -39.19 Million | -18.96 Million | -20.21 Million | -11.09 Million |
| Depreciation & Amortization | 281 Thousand | 356 Thousand | 376 Thousand | 362 Thousand | 357 Thousand | 376 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.15 Million | 654 Thousand | 3.12 Million | 213 Thousand | -973 Thousand | 560 Thousand |
| Other non-cash items | 3.91 Million | 268 Thousand | 121 Thousand | -379 Thousand | -461 Thousand | -354 Thousand |
| Investing Cash Flow | -506 Thousand | -3.82 Million | -4.62 Million | -6.38 Million | -18.21 Million | -28.86 Million |
| Investments in PPE | -506 Thousand | -3.82 Million | -4.62 Million | -6.38 Million | -18.21 Million | -28.86 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -353 Thousand | -3.69 Million | -4.25 Million | 1000.00 | -18.16 Million | -28.47 Million |
| Financing Cash Flow | 28.53 Million | 51.65 Million | 64.2 Million | 41.44 Million | 35.18 Million | 25.53 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 28.53 Million | 51.65 Million | 64.2 Million | 41.44 Million | 35.18 Million | 26.7 Million |
| Other Financing Activities | 28.53 Million | 51.65 Million | 64.2 Million | 41.44 Million | 1000.00 | -1.16 Million |
| Accounts receivables | -3.57 Million | -1.21 Million | -540 Thousand | -437 Thousand | -247 Thousand | -79 Thousand |
| Accounts payables | 420 Thousand | 1.86 Million | 3.66 Million | 650 Thousand | -726 Thousand | 96 Thousand |
| Inventory | - | -1.86 Million | -3.66 Million | -237 Thousand | 726 Thousand | - |
| Other working capital | -3.15 Million | 1.86 Million | 3.66 Million | 237 Thousand | -726 Thousand | 543 Thousand |
| Cash at beginning of period | 62.1 Million | 52.46 Million | 28.44 Million | 12.14 Million | 16.47 Million | 30.31 Million |
| Cash at end of period | 45.21 Million | 62.1 Million | 52.46 Million | 28.44 Million | 12.14 Million | 16.47 Million |
| Capital Expenditure | -506 Thousand | -3.82 Million | -4.62 Million | -6.38 Million | -18.21 Million | -28.86 Million |
| Effect of forex changes on cash | 1000.00 | - | - | - | -1000.00 | - |
| Net cash flow / Change in cash | -16.88 Million | 9.64 Million | 24.01 Million | 16.29 Million | -4.32 Million | -13.84 Million |
| Free Cash Flow | -45.41 Million | -42.01 Million | -40.19 Million | -25.15 Million | -39.5 Million | -39.37 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.15 Million | -7.76 Million | -9.41 Million | -42.22 Million | -7.2 Million | -8.03 Million |
| Depreciation & Amortization | 79 Thousand | 79 Thousand | 76 Thousand | 281 Thousand | 70 Thousand | 67 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.09 Million | -2.92 Million | -598 Thousand | -3.15 Million | 2.64 Million | -3.99 Million |
| Other non-cash items | 228.99 Thousand | 230 Thousand | -2.43 Million | 3.91 Million | -70 Thousand | -68 Thousand |
| Investing Cash Flow | -59 Thousand | -59 Thousand | 3.01 Million | -506 Thousand | -642 Thousand | -1.68 Million |
| Investments in PPE | - | - | -153 Thousand | -506 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -59 Thousand | -59 Thousand | -253 Thousand | -353 Thousand | -642 Thousand | -1.68 Million |
| Financing Cash Flow | 24.6 Million | -2.36 Million | 28.75 Million | 28.53 Million | -221 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 28.53 Million | - | - |
| Other Financing Activities | 24.6 Million | -2.36 Million | 28.75 Million | 28.53 Million | -221 Thousand | - |
| Accounts receivables | - | - | -3.57 Million | -3.57 Million | - | - |
| Accounts payables | - | - | - | 420 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.09 Million | -2.92 Million | -597 Thousand | -3.15 Million | 2.64 Million | -3.99 Million |
| Cash at beginning of period | 32.25 Million | 45.21 Million | 25.97 Million | 62.1 Million | 31.39 Million | 45.1 Million |
| Cash at end of period | 47.7 Million | 32.25 Million | 45.21 Million | 45.21 Million | 25.97 Million | 31.39 Million |
| Capital Expenditure | - | - | -153 Thousand | -506 Thousand | - | - |
| Effect of forex changes on cash | - | - | 1000.00 | 1000.00 | 1000.00 | - |
| Net cash flow / Change in cash | 15.45 Million | -12.96 Million | 19.24 Million | -16.88 Million | -5.41 Million | -13.71 Million |
| Free Cash Flow | -9.09 Million | -10.54 Million | -12.67 Million | -45.41 Million | -4.55 Million | -12.02 Million |
PIXY
VIVA
RVLV
SEEK
BMIN4
6796